跳至主要内容
临床试验/RPCEC00000327
RPCEC00000327尚未招募未知

Evaluation of the effect and safety of Biomodulina T in combination with conventional therapy in the treatment of pediatric septic shock. Exploratory Study.

Centro Nacional de Biopreparados (BioCen)0 个研究点目标入组 60 人开始时间: 2020年8月3日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
29 days 至 8 years(—)
性别
All

入选标准

  • 1. Patients who meet the diagnostic criteria.
  • 2. Patients aged = 29 days and <9 years.
  • 3. Patients whose parents or legal guardians give their consent to participate in the study in writing.

排除标准

  • 1. Patients in whom randomization is not possible within the first 24 hours of being diagnosed.
  • 2. Patients with histories of severe allergic reactions and / or generalized severe eczema.
  • 3. Patients with a diagnosis of tumor or autoimmune disease.
  • 4. Patients with a previous diagnosis of primary immunodeficiency.
  • 5. Patients with a solid organ or stem cell transplant.

研究者

发起方
Centro Nacional de Biopreparados (BioCen)

相似试验

招募中
不适用
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory studyCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusDisease PreventionAging
RPCEC00000348ational Center for Bioproducts (BioCen).60
招募中
2 期
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III.HIV InfectionsHuman Immunodeficiency VirusHIVLentiviruses InfectionsRetroviridae InfectionsRNA Viruses InfectionsSexually Transmitted Diseases, ViralImmunologic Deficiency SyndromesImmune System DiseasesEnvironmental IllnessVirus DiseasesSexually Transmitted Diseases
RPCEC00000288ational Center of Bioproducts (BIOCEN)198
招募中
3 期
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase IIIThymus hypoplasiaThymic HypoplasiaThymus Gland /abnormalities
RPCEC00000247Center National of Bioproducts (BioCen)60
招募中
不适用
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adultson-small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases
RPCEC00000358Center of Molecular Immunology (CIM)
已完成
4 期
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trialPrevention of infections, including covid-19Covid-19SARS-CoV2Disease PreventionAgingCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirus
RPCEC00000310Centro Nacional de Biopreparados (BioCen)